Related Experiment Video
Updated: May 4, 2026
08:38
A Standardized Method for the Analysis of Liver Sinusoidal Endothelial Cells and Their Fenestrations by Scanning Electron Microscopy
Published on: April 30, 2015
14.4K
Liver physiology and liver diseases in the elderly
Kazuto Tajiri1, Yukihiro Shimizu1
1Kazuto Tajiri, Third Department of Internal Medicine, Toyama University Hospital, Toyama 930-0194, Japan.
World Journal of Gastroenterology
|January 1, 2014
Summary
Aging significantly alters liver function, impacting drug metabolism and immune response. Elderly patients face increased risks for liver injury and disease complications due to reduced organ reserve and altered immunity.
Area of Science:
- Gerontology
- Hepatology
- Immunology
Background:
- Aging leads to decreased liver volume and blood flow, affecting drug metabolism and increasing susceptibility to drug-induced liver injury.
- Elderly individuals exhibit diminished immune responses to pathogens and neoplastic cells, alongside a predisposition to autoimmunity due to impaired dendritic cell maturation and reduced regulatory T cells.
Discussion:
- Age-related immune dysregulation can modify the pathogenesis of viral hepatitis, autoimmune liver diseases, and hepatocellular carcinoma.
- Reduced organ reserve in older adults compromises their tolerance to liver disease treatments, complicating clinical management.
Key Insights:
- Liver aging impacts drug metabolism, immune surveillance, and disease susceptibility.
- Age-related changes necessitate tailored approaches for managing liver diseases in the elderly.
Outlook:
- Further research into age-specific liver pathophysiology is crucial for developing targeted therapies.
- Understanding these aging effects is vital for improving clinical outcomes and treatment strategies in geriatric hepatology.
Related Concept Videos
01:30Liver Physiology
3.8K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.8K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:26Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42